Gabelli assumed coverage on shares of Sherwin-Williams (NYSE:SHW) in a report published on Friday, September 21st, Marketbeat reports. The firm issued a buy rating and a $553.00 target price on the specialty chemicals company’s stock.
Several other analysts also recently issued reports on the company. Seaport Global Securities downgraded Sherwin-Williams from a buy rating to a neutral rating in a report on Monday, September 17th. They noted that the move was a valuation call. Edward Jones started coverage on shares of Sherwin-Williams in a research report on Tuesday, September 4th. They issued a hold rating for the company. Zacks Investment Research cut shares of Sherwin-Williams from a buy rating to a hold rating in a research report on Tuesday, August 7th. Northcoast Research reissued a buy rating and issued a $465.00 price objective on shares of Sherwin-Williams in a research report on Friday, July 27th. Finally, ValuEngine raised shares of Sherwin-Williams from a hold rating to a buy rating in a research report on Thursday, July 26th. Eleven equities research analysts have rated the stock with a hold rating, twelve have given a buy rating and one has issued a strong buy rating to the stock. Sherwin-Williams presently has a consensus rating of Buy and a consensus price target of $469.42.
NYSE SHW traded down $0.25 during trading hours on Friday, hitting $406.97. The company had a trading volume of 846,634 shares, compared to its average volume of 673,189. Sherwin-Williams has a fifty-two week low of $362.36 and a fifty-two week high of $479.64. The company has a market cap of $42.51 billion, a P/E ratio of 28.52, a P/E/G ratio of 1.87 and a beta of 1.24. The company has a current ratio of 1.20, a quick ratio of 0.75 and a debt-to-equity ratio of 2.59.
Sherwin-Williams (NYSE:SHW) last announced its quarterly earnings results on Tuesday, July 24th. The specialty chemicals company reported $5.73 earnings per share (EPS) for the quarter, beating the consensus estimate of $5.59 by $0.14. Sherwin-Williams had a return on equity of 46.68% and a net margin of 10.84%. The firm had revenue of $4.77 billion during the quarter, compared to the consensus estimate of $4.65 billion. During the same period in the prior year, the firm earned $4.52 EPS. The firm’s quarterly revenue was up 27.8% compared to the same quarter last year. On average, sell-side analysts forecast that Sherwin-Williams will post 19.3 EPS for the current fiscal year.
In other news, Chairman John G. Morikis sold 20,946 shares of the stock in a transaction dated Thursday, July 26th. The shares were sold at an average price of $439.30, for a total transaction of $9,201,577.80. Following the transaction, the chairman now owns 104,907 shares of the company’s stock, valued at $46,085,645.10. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director Susan J. Kropf sold 995 shares of the stock in a transaction dated Thursday, July 26th. The stock was sold at an average price of $445.43, for a total transaction of $443,202.85. The disclosure for this sale can be found here. Insiders have sold 34,775 shares of company stock worth $15,411,619 in the last ninety days. Corporate insiders own 0.78% of the company’s stock.
Several hedge funds have recently modified their holdings of the company. LFA Lugano Financial Advisors SA acquired a new stake in Sherwin-Williams during the third quarter worth about $112,000. Summit Trail Advisors LLC raised its stake in Sherwin-Williams by 37,388.4% during the first quarter. Summit Trail Advisors LLC now owns 113,215 shares of the specialty chemicals company’s stock worth $113,000 after acquiring an additional 112,913 shares during the period. Fort L.P. acquired a new stake in Sherwin-Williams during the second quarter worth about $124,000. Valeo Financial Advisors LLC increased its stake in shares of Sherwin-Williams by 168.6% in the second quarter. Valeo Financial Advisors LLC now owns 325 shares of the specialty chemicals company’s stock valued at $142,000 after purchasing an additional 204 shares during the period. Finally, Moneta Group Investment Advisors LLC increased its stake in shares of Sherwin-Williams by 10,109.0% in the second quarter. Moneta Group Investment Advisors LLC now owns 28,279 shares of the specialty chemicals company’s stock valued at $161,000 after purchasing an additional 28,002 shares during the period. 78.91% of the stock is currently owned by institutional investors and hedge funds.
The Sherwin-Williams Company develops, manufactures, distributes, and sells paints, coatings, and related products to professional, industrial, commercial, and retail customers primarily in North and South America, the Caribbean, Europe, Asia, and Australia. The company operates in three segments: The Americas Group, Consumer Brands Group, and Performance Coatings Group.
Featured Article: Diversification in Your Portfolio
Receive News & Ratings for Sherwin-Williams Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sherwin-Williams and related companies with MarketBeat.com's FREE daily email newsletter.